| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CGH.2009.11.017 |
| P8608 | Fatcat ID | release_n5cbbw3tzrdrxl66ojr3365qym |
| P932 | PMC publication ID | 2834813 |
| P698 | PubMed publication ID | 19948245 |
| P5875 | ResearchGate publication ID | 40041381 |
| P50 | author | Karl E Anderson | Q104585431 |
| P2093 | author name string | James J Grady | |
| Chul Lee | |||
| Sajid Jalil | |||
| P2860 | cites work | Smoking rate trends in U.S. occupational groups: the 1987 to 2004 National Health Interview Survey | Q23911744 |
| A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda | Q24681370 | ||
| Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study | Q28270234 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey | Q30977059 | ||
| Iron as a co-morbid factor in nonhemochromatotic liver disease | Q35212534 | ||
| Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. | Q35217843 | ||
| The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population | Q36068238 | ||
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association | Q42982870 | ||
| Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. | Q42986887 | ||
| The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients | Q42987489 | ||
| Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America | Q42988426 | ||
| Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q43624937 | ||
| C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients | Q43703709 | ||
| C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria | Q43929897 | ||
| Defining nonalcoholic fatty liver disease: implications for epidemiologic studies | Q44269279 | ||
| Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients | Q44460264 | ||
| Hepatocellular carcinoma risk in patients with porphyria cutanea tarda | Q44939968 | ||
| Extrahepatic manifestations of hepatitis C among United States male veterans | Q45333951 | ||
| Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency | Q45713240 | ||
| Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection | Q45739053 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. | Q46443909 | ||
| Prevalence of HIV infection in the United States, 1984 to 1992. | Q46634922 | ||
| Porphyria cutanea tarda in a Swedish population: risk factors and complications | Q46726444 | ||
| The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. | Q50986042 | ||
| HFE genotype and transferrin saturation in the United States | Q57608788 | ||
| The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda | Q58227799 | ||
| Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States | Q64129477 | ||
| Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France | Q73209346 | ||
| CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron | Q73344857 | ||
| Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda | Q73479476 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | porphyria cutanea tarda | Q1479497 |
| P304 | page(s) | 297-302, 302.e1 | |
| P577 | publication date | 2009-11-27 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Associations among behavior-related susceptibility factors in porphyria cutanea tarda | |
| P478 | volume | 8 |
| Q34699532 | CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda |
| Q40051609 | Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C. |
| Q92046226 | Heme biosynthesis and the porphyrias |
| Q38994896 | Hepatic porphyria: A narrative review |
| Q39392013 | Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda |
| Q55231652 | Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells. |
| Q34268811 | Hepatitis C, porphyria cutanea tarda and liver iron: an update |
| Q34300246 | Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda |
| Q37973341 | Peripheral ulcerative keratitis and necrotizing scleritis initiated by trauma in the setting of mixed cryoglobulinemia |
| Q55392564 | Porphyria Cutanea Tarda Presenting with Scleroderma, Ichthyosis, Alopecia, and Vitiligo. |
| Q36267789 | Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias |
| Q91227989 | Porphyria cutanea tarda: Recent update |
| Q92069061 | Sporadic Porphyria Cutanea Tarda as the Initial Manifestation of Hereditary Hemochromatosis |
| Q37078233 | Sun, iron, alcohol and intrinsic liver disease: a recipe for failure. |
| Q36142859 | The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda. |
| Q44143427 | The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort |
Search more.